共 12 条
- [1] Cost-Utility Analysis of Fixed-Dose Combination of Indacaterol Acetate Glycopyrronium Bromide and Mometasone Furoate as a Maintenance Treatment in Adult Patients with Asthma Not Adequately Controlled with a Maintenance Combination of a Long-Acting Beta-Agonist and a High Dose of an Inhaled Corticosteroid Who Experienced One or More Asthma Exacerbations in the Previous YearCLINICAL DRUG INVESTIGATION, 2021, 41 (09) : 785 - 794Mangia, Pier PaoloGallo, OttavioRitrovato, DanielaPradelli, Lorenzo
- [2] COST-UTILITY ANALYSIS OF FIXED DOSE COMBINATION (FDC) OF INDACATEROL ACETATE (IND) GLYCOPYRRONIUM BROMIDE (GLY) AND MOMETASONE FUROATE (MF) AS A MAINTENANCE TREATMENT IN ADULT ASTHMA PATIENTS NOT ADEQUATELY CONTROLLED WITH A MAINTENANCE COMBINATION OF A LONG-ACTING BETA2-AGONIST AND A HIGH DOSE OF AN INHALED CORTICOSTEROID WHO EXPERIENCED ONE OR MORE ASTHMA EXACERBATIONS IN THE PREVIOUS YEARVALUE IN HEALTH, 2020, 23 : S719 - S719Mangia, P. P.Pradelli, L.Gallo, O.Ritrovato, D.Gupta, S.
- [3] COST-UTILITY ANALYSIS OF FIXED DOSE COMBINATION (FDC) OF INDACATEROL ACETATE (IND) AND MOMETASONE FUROATE (MF) AS A MAINTENANCE TREATMENT OF ASTHMA IN PATIENTS NOT ADEQUATELY CONTROLLED WITH INHALED CORTICOSTEROIDS AND INHALED SHORT ACTING BETA2-AGONISTSVALUE IN HEALTH, 2020, 23 : S721 - S722Mangia, P. P.Pradelli, L.Gallo, O.Ritrovato, D.Gupta, S.
- [4] Serious Asthma Outcomes and Asthma Exacerbations with Maintenance on Inhaled Corticosteroid (Mometasone Furoate)/Long-Acting Beta Agonist (Formoterol) Combination Compared to Step Down to Mometasone MonotherapyJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (05): : 1634 - +Weinstein, Cindy L. J.Ryan, NicholasZhang, XiaoliShekar, TulinGates, DavisLane, Stephen J.Agache, IoanaNathan, Robert A.
- [5] Serious Asthma Outcomes and Asthma Exacerbations with Maintenance on Inhaled Corticosteroid (Mometasone Furoate)/Long-Acting Beta Agonist (Formoterol) Combination Compared to Step-Down to Mometasone MonotherapyAMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197Weinstein, C. L. J.Gates, D.Ryan, N.Zhang, X.Shekar, T.Lane, S. J.Agache, I. O.Nathan, R. A.
- [6] FIXED DOSE COMBINATION (FDC) OF INDACATEROL ACETATE (IND) AND MOMETASONE FUROATE (MF) AS A MAINTENANCE TREATMENT OF ASTHMA IN PATIENTS NOT ADEQUATELY CONTROLLED WITH INHALED CORTICOSTEROIDS AND INHALED SHORT ACTING BETA2-AGONISTS: A BUDGET IMPACT ANALISYS IN ITALYVALUE IN HEALTH, 2020, 23 : S724 - S724Mangia, P. P.Pradelli, L.Gallo, O.Ritrovato, D.Ting, B.
- [7] Once-Daily Indacaterol Acetate, Glycopyrronium Bromide, and Mometasone Furoate as a Fixed-Dose Combination in Japanese Patients with Inadequately Controlled Asthma: A Multicenter, 52-Week Safety StudyAMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201Sagara, H.D'Andrea, P.Tanase, A.Pethe, A.Tanaka, Y.Matsuo, K.Hosoe, M.
- [8] PREVALENCE OF ASTHMA CONTROL AND THE ASSOCIATED DISEASE BURDEN IN US PATIENTS WITH ASTHMA TREATED WITH A FIXED-DOSE COMBINATION OF INHALED CORTICOSTEROID AND LONG-ACTING BETA2-AGONISTCHEST, 2020, 158 (04) : 1793A - 1794AZhang, ShiyuanWhite, JohnMeeraus, WilhelmineHinds, DavidMurali, SharanyaTabberer, MaggieSansbury, LeahFowler, AndrewLee, LaurieHunter, Alyssa Goolsby
- [9] Single inhaler combination inhaled corticosteroid-formoterol as both maintenance and reliever (SMART) compared with a step up of treatment with fixed-dose inhaled corticosteroid-long-acting β2-agonist maintenance with a short-acting β2-agonist as reliever in adolescents and adults with poorly controlled asthma in Colombia: a cost-utility analysisJOURNAL OF ASTHMA, 2025, 62 (03) : 500 - 507Rodriguez-Martinez, Carlos E.Sossa-Briceno, Monica P.Castro-Rodriguez, Jose A.
- [10] Symptom-driven inhaled corticosteroid/long-acting beta-agonist therapy for adult patients with asthma who are non-adherent to daily maintenance inhalers: a study protocol for a pragmatic randomized controlled trialTrials, 23James G. KringsKaitlyn M. WojcikVanessa ChenTejas C. SekharKelly HarrisAbigail ZulichKaharu SuminoRoss BrownsonEric LenzeMario Castro